We compared, in volunteers, the effect of propofol (PROP) and dexmedetomidine (DEX) sedation on autonomic nervous activities and subjective feelings during psychological stresses. In a crossover design, 25 subjects received PROP and DEX titrated to a bispectral index value of 75 to 85. Heart rate, heart rate variability, and salivary ␣-amylase (objective indices) and a faces anxiety scale (subjective index) were assessed. Subjects were asked their preference between 2 sedatives. Objective indices showed similar changes in both groups. The faces anxiety scale decreased only in the PROP group and subjects preferred PROP. Propofol more effectively suppressed anxious feelings compared with DEX during sedation. (Anesth Analg 2010;110:415-8) Mi dazolam and propofol (PROP) are frequently used for IV sedation in dentistry. 1-4 PROP possesses antiemetic activities along with rapid onset and clear recovery. 5-9 Dexmedetomidine (DEX) provides mild analgesia and amnesia without major cardiorespiratory depression. 10 -12 Recently, DEX has been proposed for IV sedation during dental treatment. [13] [14] [15] However, there are no comparative studies on the effect of PROP and DEX on autonomic nervous activities and subjective feelings during sedation. This study was designed to examine how PROP or DEX sedation affects autonomic nervous activities and subjective feelings under psychological stresses.
We compared, in volunteers, the effect of propofol (PROP) and dexmedetomidine (DEX) sedation on autonomic nervous activities and subjective feelings during psychological stresses. In a crossover design, 25 subjects received PROP and DEX titrated to a bispectral index value of 75 to 85. Heart rate, heart rate variability, and salivary ␣-amylase (objective indices) and a faces anxiety scale (subjective index) were assessed. Subjects were asked their preference between 2 sedatives. Objective indices showed similar changes in both groups. The faces anxiety scale decreased only in the PROP group and subjects preferred PROP. Propofol more effectively suppressed anxious feelings compared with DEX during sedation. (Anesth Analg 2010; 110:415-8) Mi dazolam and propofol (PROP) are frequently used for IV sedation in dentistry. [1] [2] [3] [4] PROP possesses antiemetic activities along with rapid onset and clear recovery. [5] [6] [7] [8] [9] Dexmedetomidine (DEX) provides mild analgesia and amnesia without major cardiorespiratory depression. 10 -12 Recently, DEX has been proposed for IV sedation during dental treatment. [13] [14] [15] However, there are no comparative studies on the effect of PROP and DEX on autonomic nervous activities and subjective feelings during sedation. This study was designed to examine how PROP or DEX sedation affects autonomic nervous activities and subjective feelings under psychological stresses.
METHODS
This study was approved by the Clinical Research Ethics Committee at Tokyo Dental College, and all subjects signed a written consent. Twenty-five healthy adult male volunteers who had no experience of PROP and DEX sedation received PROP and DEX in a crossover manner. Subjects were prohibited from smoking and drinking liquids other than water for 2 hours before the experiment.
Subjects were seated in a resting position in a dental chair. Arterial oxygen saturation (Spo 2 ) and bispectral index (BIS) (Aspect, BIS Monitor A-2000, Nihon Kohden, Tokyo, Japan) were monitored. Heart rate variability (HRV) was analyzed with the MemCalc/Tarawa software (Suwa Trust, Tokyo, Japan). R-R interval was analyzed every 2 seconds. Low frequency/high frequency ratio (LF/HF) and normalized unit LF (nuLF) (indices of sympathetic nervous activities) and normalized unit HF (nuHF) (an index of parasympathetic nervous activities) were determined. Heart rate (HR) and HRV data were averaged for 3 minutes just before each mental arithmetic (MA) task and for the last 3 minutes of each MA task.
After an IV line was secured, subjects were directed to close their eyes except during completion of the MA task. Data were taken after confirming autonomic nervous stability with LF/HF at 1 or lower. Before MA testing, at time point C1, HR, HRV, BIS value, and Spo 2 were recorded ( Fig. 1 ). The first MA task (MA1) of 4-digit numbers subtractions was then begun. A subtraction was shown on a personal computer screen. Subjects were directed to respond within 12 seconds, and then the next subtraction was shown on the screen. The total task duration was 7 minutes. At completion of MA1 (time point S1), subjective feelings were evaluated as 0 to 5 on faces anxiety scale (FAS). FAS score of 0 meant no stress and 5 the worst. 16 -20 HR and HRV were observed, and saliva was collected to assess salivary ␣-amylase (AMY).
One to 2 minutes after saliva collection, PROP or DEX infusion was started. In the PROP group, PROP (Diprivan™, AstraZeneca, Osaka, Japan) was infused in a target-controlled infusion mode at an initial effect-site concentration of 0.7 g/mL. In the DEX group, DEX (Precedex™, Maruishi Pharmaceutical, Osaka, Japan) was administered with an initial loading dose of 0.1 g/kg followed by 0.4 g ⅐ kg Ϫ1 ⅐ h Ϫ1 . Based on our preliminary experiment, we verified that the targeted sedation level of 75 to 85 BIS value was achieved with these doses. We confirmed an Observer's Assessment of Alertness/Sedation score of 4 at this BIS level in all subjects. The second MA task (MA2) was begun 10 to 15 minutes after the start of infusion when sedation variables and autonomic nervous activities were stable. Immediately before MA2, HR, HRV, BIS value, and Spo 2 were recorded (time point C2). At the completion of MA2, FAS score, HR, HRV, and AMY were again obtained (time point S2). Drug administration was then discontinued. Subjects returned for the second infusion session 7 days after the first session. After complete recovery from the second experiment, subjects were asked their preference for PROP or DEX based on subjective feelings during sedation.
A sample size of 25 subjects was determined based on our preliminary study in which statistical significance of the changes in HR, HRV, and a FAS score was ensured at a level of ␣ error of 0.05 and ␤ error of 0.8. The order of the drug administered was randomized. Repeated-measures analysis of variance followed by 
RESULTS
In the PROP group, HR, LF/HF, nuLF, and nuHF before and after MA1 were comparable. In the DEX group, HR and nuLF slightly decreased, whereas nuHF slightly increased, after MA1 compared with those before MA1. There were no intergroup differences in these variables. During MA1, HR, LF/HF, and nuLF increased, whereas nuHF decreased, from those before MA1 in both groups.
During sedation, BIS values showed similar decreases in both groups. Spo 2 decreased only in the PROP group. During MA2, HR, LF/HF, and nuLF increased, whereas nuHF decreased, from those before MA2 in both groups. HR during MA2 was slower than MA1 in both groups. LF/HF and nuLF were larger, whereas nuHF was smaller, during MA2 than MA1 in the PROP group. Changes in these variables during MA1 and MA2 were comparable in the DEX group. However, there were no intergroup differences in these variables. FAS scores and correct answer rates during MA2 were lower than MA1 in the PROP group. In the DEX group, these values did not change. AMY during MA2 was lower than MA1 in both groups. Seventeen subjects preferred PROP and no subjects preferred DEX (Table 1, Fig. 2 ).
DISCUSSION
Results of this study showed that in volunteers, a simple arithmetic subtraction test provided evidence of anxiety as measured by changes in autonomic activity and the FAS score. At mild sedation levels (BIS 75-85), anxiety was better prevented with PROP Figure 1 . Schematic diagram depicting the experimental protocols. BIS ϭ bispectral index; Spo 2 ϭ arterial oxygen saturation; FAS ϭ faces anxiety scale; HR ϭ heart rate; HRV ϭ HR variability; AMY ϭ salivary ␣-amylase; MA ϭ mental arithmetic (task); C1 ϭ before the start of first MA (MA1); C2 ϭ before the start of second MA (MA2); S1 ϭ at the finish of first MA (MA1); S2 ϭ at the finish of second MA (MA2). Values are mean Ϯ SD (n ϭ 25). C1 ϭ before the start of first mental arithmetic task (MA1); C2 ϭ before the start of second mental arithmetic task (MA2); S1 ϭ at the finish of first mental arithmetic task (MA1); S2 ϭ at the finish of second mental arithmetic task (MA2). * P Ͻ 0.05 versus C1, † P Ͻ 0.05 versus S1, ‡ P Ͻ 0.05 versus C2, § P Ͻ 0.05 between 2 groups. than DEX. FAS scores decreased during PROP sedation but not during DEX sedation, despite no significant intergroup differences in autonomic nervous activities. FAS is easy to use and has been shown suitable for rapid observation of anxiety in intensive care unit patients and correlates well with the Hospital Anxiety and Depression Scale. 19, 20 The target sedation level was a BIS value of 75 to 85 and Observer's Assessment of Alertness/Sedation score of 4. 21 This sedation level might be relatively light compared with that in clinical settings. This sedation level was used to enable the subjects to complete the MA task. A similar sedation level was obtained with a target effect-site concentration of 0.7 g/mL PROP and DEX at an initial dose of 0.1 g/kg followed by 0.4 g ⅐ kg Ϫ1 ⅐ h Ϫ1 . The 4-digit MA task is a reliable method for psychological stress and is widely accepted in the psychological research field. 16 -18 We observed changes in subjective anxiety and sympathetic activity during performance of the MA test. Seven minutes seems to be an appropriate time interval to complete the MA task during the level of sedation provided.
Before drug administration, HR, LF/HF, and nuLF increased whereas nuHF decreased in both groups after the MA task. These results were consistent with a report that showed an MA task increased LF and decreased HF. 22 Previously, AMY was shown to reflect psychological stress when subjects were directed to perform a 4-digit MA task. 17 In our study, AMY also decreased after sedation in both groups. These results suggest that the MA task provides an adequate stressor and both PROP and DEX sedation inhibited sympathetic activation during psychological stresses.
DEX produces only mild respiratory depression. 12 In this study, Spo 2 was unchanged during DEX sedation but did decrease with PROP. This is a beneficial effect of DEX. However, we found that the FAS score decreased only during PROP sedation. Although sympathetic activation due to an MA task was predicted during DEX sedation, the results showed similar autonomic activities in both groups. These results may indicate that the sympathetic inhibition by DEX is stronger than that of PROP.
There are some limitations to this study. As this was not a double-blind study, possible bias might have occurred when the subjective assessments were performed. The MA task was used as a simulated and standardized psychological stress in healthy adult volunteers; however, patients have much larger individual variations in anxiety treatment.
In conclusion, because DEX failed to reduce subjective stress produced by an MA task during light sedation, PROP may be more suitable than DEX for IV sedation of anxious patients because of better subjective feelings. The majority of our subjects expressed a preference for PROP rather than DEX. Figure 2 . Impact of a math task on autonomic variables after sedation provided by propofol (PROP) or dexmedetomidine (DEX). Low frequency/high frequency ratio (LF/HF) at S1 and S2 were higher than that at C1 and C2 in both groups. LF/HF at S2 was higher than that at S1 in the PROP group. Normalized unit LF (nuLF) at S1 and S2 were higher than that at C1 and C2 in both groups. nuLF at S2 was higher than that at S1 in the PROP group. nuLF at C2 was lower than that at C1 in the DEX group. nuHF at S1 and S2 were lower than that at C1 and C2 in both groups. nuHF at S2 was lower than that at S1 in the PROP group. nuHF at C2 was higher than that at C1 in the DEX group. C1 ϭ before the start of first mental arithmetic (MA) task (MA1); C2 ϭ before the start of second MA (MA2); S1 ϭ at the finish of first MA (MA1); S2 ϭ at the finish of second MA (MA2). *P Ͻ 0.05 versus C1, **P Ͻ 0.05 versus S1, ***P Ͻ 0.05 versus C2, †P Ͻ 0.05 between 2 groups. Vol. 110, No. 2, February 2010
